Olexiy TKACHENKO, Maryna BILAN, Volodymyr HLEBENIUK, Natalia ALEKSEEVA, Vitalii NEDOSEKOV, Olexandr GALATIUK

Chronology of Morphological Forms of Mycobacterium bovis Rapid-Growing Strain

The study aimed to examine the changes observed in the morphology of rapid-growing tuberculosis pathogen strain, degree of pathogenicity, sensitized properties, and content of lipids, which depend on the pH of the medium, for 180 inoculations of 1–3 days culture. The reversion of non–acid-resistant forms of Mycobacterium bovis of the rapid-growing strain to bacterial acid-resistant forms occurred because of the following reasons: formation of non–acid-resistant grains in thread-like M. bovis, transformation and fragmentation of non– acid-resistant thread-like forms into acid-resistant rod-shaped bacteria, and output from non–acid-resistant thread-like M. bovis acid-resistant forms. It was found that increasing the number of passages of M. bovis of the rapid-growing strain through the medium at pH 6.7 led to a probable decrease (p

PDF

___

Ahrem, A.A., Kuznecova, A.I., 1964. Thin layer chromatography, 176. Behr, M.A., 2001. Correlation between BCG genomics and protective efficacy. Scandinavian Journal of Infectious Diseases 33, 249-252. [Crossref]

Bilan, M.V., Tkachenko O.A., Kovaleva L.O., 2007. Free fatty acids - pathogenicity factors of M. bovis. Collection of scientific works of Lugansk National Agrarian University 78, 613-620.

Stead, W.W., Bates, J.H., 2000. Recurrent tuberculosis due to exogenous reinfection. The New England Journal of Medicine, 342, 1050-1051. [Crossref]

Djachenko, G.M., Kravchenko, N.O., Golovach, O.V., Dmytruk, O.M., Il’i’nyh, V.V., 2008. Minlyvist’ fenotypovyh oznak mikobakterij riznyh vydiv za nabutoi’ medykamentoznoi’ stijkosti [Mix of phenotypic signs of mycobacterium other visions for medication].

Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences 3, 72-77 (in Ukrainian).

Domingue, G.J., Woody, H.B., 1997. Bacterial persistence and expression of disease. Clinical Microbiology Reviews 10, 320-344. [Crossref]

Downing, K.J., Mischenko, V.V., Shleeva, M.O., Young, D.I., Young, M., Kaprelyants, A.S., Apt, A.S., Mizrahi, V., 2005. Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro. Infection and Immunity 73, 3038-3043. [Crossref]

Fine, P.E., 1995. Variation in protection by BCG: implication of and for heterologous immunity. Lancet 346, 1339-1345. [Crossref]

Glebenyuk, V.V., Telijenko, K.V., 2015. Vydova nalezhnist mikobakterii, vydilenykh vid tvaryn u Dnipropetrovskii oblasti [Species affiliation of mycobacterium isolated from animals in the Dnipropetrovsk region]. Scientific and Technical Bulletin of the National State Center of Biosafety and Environmental Control of Resources of Agro-industrial Complex 3, 1-4. (in Ukrainian). http://biosafety-center.com/wp-content/uploads/2015/06/2.pdf

Green, M.T., Heidger, P.M., Jr, Domingue, G., 1974. Demonstration of the phenomena of microbial persistence and reversion with bacterial L-forms in human embryonic kidney cells. Infection and Immunity 10, 889-914. [Crossref]

Gutman, L.T., Turck, M., Petersdorf, R.G., Wedgwood, R.J., 1965. Significance of bacterial variants in urine of patients with chronic bacteriuria. The Journal of Clinical Investigation 44, 1945-1952. [Crossref]

Guze, L.B., Harwich, H.J., Kalmanson, G.M., 1976. Klebsiella L-forms: effect of growth as L-form on virulence of reverted Klebsiella pneumoniae. The Journal of Infectious Diseases 133, 245-252. [Crossref]

Horwitz, M.A., Harth, G., 2003. A new vaccine against tuberculosis affords greater survival after challenge than current vaccine in the guinea pig model of pulmonary tuberculosis. Infection and Immunity 71, 1672-1679. [Crossref]

Kalina, G.P., 1962. Filtruyuschiesya formyi bakteriy (Rukovodstvo po mikrobiologii, klinike i epidemiologii infektsionnyih bolezney) [Filtering forms of bacteria (Guide to Microbiology, Clinic and Epidemiology of Infectious Diseases)]. Moscow, Medgiz 432-473. (in Russian).

Keits, M., 1975. Tekhnika lipidologii. Vydelenie, analiz i identifikatsiya lipidov [Lipidology technique. Isolation, analysis and identification of lipids]. Moscow, Mir, 322. (in Russian).

Kochemasova, Z.N., Dykhne, M.M., Dorozhkova, I.R., 1980. L-formy mykobakterij tuberkuloza [L-Forms of Mycobacterium tuberculosis]. Moscow, Medicina 165. (in Russian).

Leon, O., Panos, C., 1976. Adaptation of an osmotically fragile L-form of Streptococcus pyogenes to physiological osmotic conditions and its ability to destroy human heart cells in tissue culture. Infection and Immunity 13, 252-262. [Crossref]

Lisle, G.W., Wards, B.J., Buddle, B.M., Collins, D.M., 2005. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium. Tuberculosis 85, 73-79. [Crossref]

Majlessi, L., Brodin, P., Brosch, R., Rojas M.J., Khun, H., Huerre, M., Cole, S.T., Leclerc C., 2005. Influence of ESAT-6 secretion system1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. The Journal of Immunology 174, 3570-3579. [Crossref]

Manchenko, V.M., Trocenko, Z.R., Pavlenko, M.S., 1994. Nastanova po diagnostyci tuberkul’ozu [Guidelines for diagnosing tuberculosis], 39 (in Ukrainian).

Markova, N., Slavchev, G., Michailova, L., 2012. Filterable forms and L-forms of Mycobacterium bovis BCG: impact for live vaccina features Human Vaccines & Immunotherapeutics 8, 759-764. [Crossref]

Mattman, L.H., Tunstall, L.H., Mathews, W.W., Gordon, D.L., 1960. L-variation in mycobacteria. American Review of Respiratory Diseases 82, 202-211.

McDonald, P.J., Wetherall, B.L., Pruul, H., 1981. Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes. Reviews of Infectious Diseases 3, 38-44. [Crossref]

Michailova, L., Kussovski, V., Radoucheva, T., Jordanova, M., Berger, W., Rinder, H., Markova, N., 2005. Morphological variability and cell-wall deficiency in Mycobacterium tuberculosis ‘heteroresistant’ strains. International Journal of Tuberculosis and Lung Diseases 9, 907-914.

Phelan, J.E., Coll, F., Bergval, I., Anthony, R.M., Warren, R., Sampson, S.L., Gey van Pittius, N.C., Glynn, J.R., Crampin, A.C., Alves, A., Bessa, T.B., Campino, S., Dheda, K., Grandjean, L., Hasan, R., Hasan, Z., Miranda, A., Moore, D., Panaiotov, S., Perdigao, J., Portugal, I., Sheen, P., de Oliveira Sousa, E., Streicher, E.M., van Helden, P.D., Viveiros, M., Hibberd, M.L., Pain, A., McNerney, R., Clark, T.G., 2016. Recombination in pe/ppe genes contributes to genetic variation in Mycobacterium tuberculosis lineages. BMC Genomics 17, 151-163. [Crossref]

Ponig, B., Domingue, G., Schlegel, J., 1972. The role of in vitro induced microbial L-forms in experimental hematogenous pyelonephritis. Invest Urol. 9, 282-285.

Prozorovskiy, S.V., Kats, L.N., Kagan, G.Ya., 1981. L-formyi bakteriy [L-forms of bacteria]. Moscow, Medicine, 239. (in Russian).

Pym, A.S., Brodin, P., Majlessi, L., Brosch, R., Demangel, C., Williams, A., Griffiths, K.E., Marchal, G., Leclerc, C., Cole, S.T., 2003. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nature Medicine 9, 533-539. [Crossref]

Rao, V., Dhar, N., Tyagi, A.K., 2003. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in Bacille Calmette-Guerin. The Scandinavian Journal of Immunology 58, 449-461. [Crossref]

Rumachik, I.I., 1989. Sravnitel’noe ispytanie razlichnyh probok pri kul’tivirovanii mikobakterij [Comparative testing of various plugs in the cultivation of mycobacteria]. Veterinarija 1, 62-63 (in Russian).

Sambandamurthy, V.K., Derrick, S.C., Jalapathy, K.V., Chen, B., Russell, R.G., Morris, S.L., Jacobs, W.R., Jr, 2005. Long-term protection against tuberculosis following vaccination with severely attenuated double lysine and pantothenate auxotroth of Mycobacterium tuberculosis. Infection and Immunity 73, 1196-1203. [Crossref]

Schmitt-Slomska, L., Drach, G., Caravano, R., 1973. Incidence of cellular and humoral factors on group A streptococcal L-forms. I. Microscopic study of the association of L-forms with human, polymorphonuclear leukocytes and mouse peritoneal macrophages. Annals of Microbiology 124, 329-350.

Suutari, M., Laakso, S., 1993. Effect of -growth temperature on the fatty acid composition of Mycobacterium phlei. Archives of Microbiology 159, 119-123. [Crossref]

Timakov, V.D., Kagan, G.Y, 1973. L-formyi bakteriy i semeystvo Mycoplasmataceae v patologii [L-forms of bacteria and family Mycoplasmataceae in pathology]. Moscow, Medicine, 392. (in Russian).

Tkachenko, O., Bilan, M., Hlebeniuk, V., Kozak, N., Nedosekov, V., Galatiuk O., 2020. Dissociation of Mycobacterium bovis: morphology, biological properties and lipids. Advances in Animal and Veterinary Sciences 8, 312-326. [Crossref]

Tkachenko, O.A., 2004. Shvydkorostuchi M. bovis u problem tuberkul’ozu [Rapid-growing M. bovis in the problem of tuberculosis]. Veterinarna medicina Ukrai’ny 7, 14-17. (in Ukrainian).

Tkachenko, O.A., Davydenko, P.O., Zazhars’kyj, V.V., Brygadarenko, V.V., 2016. Biologichni vlastyvosti dysociatyvnyh L- ta inshyh form M. bovis [Biological properties of dissociative L- and other forms of M. bovis]. Visnyk of Dnipropetrovsk University. Biology, ecology. 24, 338-346. (in Ukrainian). doi:10.15421/011644. [Crossref]

Tkachenko, O.A., Kovaleva L.O., 2008. Kharakterystyka vilnykh zhyrnykh kyslot M. bovis [Characteristics of free fatty acids M. bovis]. Collection of scientific works of the Kharkov State Zoological Academy 16, 52-57. (in Ukrainian).

Tkachenko, O.A., Usejeva, N.G., Glebenjuk, V.V., Kulishenko, O.M., 2007. Biologichna aktyvnist epizootychnyh ta muzejnyh shtamiv M. bovis [Biological activity of the epizootic and museum strains M. bovis]. Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies 3, 218-224. (in Ukrainian).

Tkachenko, O.A., Zazharskyi, V.V., Hlebeniuk, V.V., 2012. Kord-faktor ta virulentnist Mycobacterium bovis shvydkorosloho shtamu ta atypovykh mikobakterii [Cord factor and virulence of Mycobacterium bovis rapid-growing strain and atypical mycobacteria]. Veterinarna Medicina Ukrai’ny 10, 10-13. (in Ukrainian).

Udou, T., Ogawa, M., Mizuguchi, Y., 1982. Spheroplast formation of Mycobacterium smegmatis and morphological aspects of their reversion to the bacillary form. Journal of Bacteriology 151, 1035- 1039. [Crossref]

Veisfeiler J., 1975. Biology and variability of Mycobacterium tuberculosis and atypical mycobacteria. Budapest: Hungarian Academy of Sciences, Budapest, 335. (in Russian).

Zykin, L.F., Dunaev, G.S., Saiamov, S.R., Sokolov, P.S., 1989. Yersinia pestis L-forms in rodents and ectoparasites. Journal Epidemiology, Microbiology, Immunology 2, 36-40.